Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?

Authors: Beat Müllhaupt, Philip Bruggmann, Florian Bihl, Sarah Blach, Daniel Lavanchy, Homie Razavi, Sarah Robbins Scott, David Semela, Francesco Negro

Source: PLoS ONE, Vol 13, Iss 12, p e0209374 (2018)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/415dcd6bb09a4c10890fad1f14eebeb4

Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030

Authors: Philip Bruggmann, Sarah Blach, Pierre Deltenre, Jan Fehr, Roger D. Kouyos, Daniel Lavanchy, Beat Müllhaupt, Andri Rauch, Homie Razavi, Patrick Schmid, David Semela, Marcel Stöckle, Franco Negro

Source: Swiss Medical Weekly, Vol 147, Iss 4546 (2017)

Subject Terms: HCV, hepatitis C virus, incidence, model, people who inject drugs, prevalence, Medicine

File Description: electronic resource

Relation: https://www.smw.ch/index.php/smw/article/view/2405; https://doaj.org/toc/1424-3997

Access URL: https://doaj.org/article/cfba0c4d892945d6963d5cce91f0cf31

Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland

Authors: Philip Bruggmann, Francesco Negro, Florian Bihl, Sarah Blach, Daniel Lavanchy, Beat Müllhaupt, Homie Razavi, David Semela

Source: Swiss Medical Weekly, Vol 145, Iss 4950 (2015)

Subject Terms: Switzerland, screening, diagnosis, Hepatitis C virus (HCV), birth cohort, Medicine

File Description: electronic resource

Relation: https://www.smw.ch/index.php/smw/article/view/2111; https://doaj.org/toc/1424-3997

Access URL: https://doaj.org/article/e921cc11cb1a487ba52f77f95cca1dfb

Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland.

Authors: Beat Müllhaupt, Philip Bruggmann, Florian Bihl, Sarah Blach, Daniel Lavanchy, Homie Razavi, David Semela, Francesco Negro

Source: PLoS ONE, Vol 10, Iss 6, p e0125214 (2015)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/f1eb1a93b2254aa5a9edb84f71610c72

Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C.

Authors: Alena M Pfeil, Oliver Reich, Ines M Guerra, Sandrine Cure, Francesco Negro, Beat Müllhaupt, Daniel Lavanchy, Matthias Schwenkglenks

Source: PLoS ONE, Vol 10, Iss 5, p e0126984 (2015)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC4431849?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/e4652a01ff194d0eb23c3be856573f71

Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection

Authors: Rainer Fretz, Francesco Negro, Philip Bruggmann, Daniel Lavanchy, Andrea De Gottardi, Isabelle Pache, Virginie Masserey Spicher, Andreas Cerny

Source: Swiss Medical Weekly, Vol 143, Iss 1920 (2013)

Subject Terms: Chronic hepatitis infection, HBV, HCV, risk groups, screening, Testing, Medicine

File Description: electronic resource

Relation: https://www.smw.ch/index.php/smw/article/view/1681; https://doaj.org/toc/1424-3997

Access URL: https://doaj.org/article/235b9c66f25641ee8808498c5188ef97

Hepatitis C

Authors: Daniel Lavanchy, Pilar Gavinio

Source: Canadian Journal of Gastroenterology, Vol 14, Iss Suppl B, Pp 67B-77B (2000)

Subject Terms: Diseases of the digestive system. Gastroenterology, RC799-869

File Description: electronic resource

Relation: https://doaj.org/toc/0835-7900

Access URL: https://doaj.org/article/4fd50e7082bb497d8f49adcd7caca026